GlobeNewswire

argenx (Nasdaq: ARGX) Rings The Nasdaq Stock Market Opening Bell in Celebration of Its IPO

mo_051817_hires-3

argenx (Nasdaq:ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, visits the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
NASDAQ, Inc.
Format

JPEG

Source

Nasdaq, Inc.

Downloads